Agios Pharmaceuticals

Company name
Agios Pharmaceuticals
Company address
88 Sidney Street
Cambridge MA 02139-4169
Contact email
Holly.manremovening@agios.com
Website
www.agios.com
Contact
Associate Director
Name
Barden Chan
Email
Bardremoveen.chan@agios.com
Tel
617-649-8600
Contact 2
VP Biology
Name
Kevin Marks
Email
Kevin.mremovearks@agios.com
Tel
617-649-8600
Porphyria Related Activities
Agios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic diseases through scientific leadership in the field of cellular metabolism and adjacent areas of biology. We currently have an active preclinical program in evaluating strategies to treat erythroid porphyrias. Our interest is to leverage our knowledge of metabolism, biology, and genomics to develop medicines to help porphyria patients by tackling the root cause of the disease through systemic reduction of porphyrins.